MannKind Corporation: shareholders and insiders

MNKDNASDAQHealthcare · Pharmaceutical Preparations

Price

$4.07

November 18, 2026Market cap $1.3B

What Ploutos Investor adds for MannKind

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from 2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Sep 28, 2026, from their own Form 4 filings.

10 Form 4s

Bought on the market

$259.0K

1 person

Sold on the market

$3.2M

4 people

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan100%
  • The rest0%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $259.0K by 1 person·sold $1.1M by 3 people

  • 2025: no buys, sold $2.1M by 2 people
  • 2026: bought $259.0K by 1 person, sold $1.1M by 3 people
  • Sep 25, 2026Steven B. BinderDirector
    Kind10b5-1
  • Sep 10, 2026Steven B. BinderDirector
    Kind10b5-1
  • Aug 7, 2026Steven B. BinderDirector
    Kind10b5-1
  • Jul 17, 2026David ThomsonEVP Genl Counsel & Secretary
    Kind10b5-1
  • Jul 17, 2026Steven B. BinderDirector
    Kind10b5-1
  • Jul 15, 2026Christopher B PrentissChief Financial Officer
    Kind
  • Jul 15, 2026Christopher B PrentissChief Financial Officer
    Kind
  • Jul 15, 2026Dominic MarascoPres, Endocrine Business Unit
    Kind
  • Jul 15, 2026Stuart A TrossChief People & Workpl Officer
    Kind
  • Jul 15, 2026Stuart A TrossChief People & Workpl Officer
    Kind
  • Jul 15, 2026Stuart A TrossChief People & Workpl Officer
    Kind
  • Jul 15, 2026Stuart A TrossChief People & Workpl Officer
    Kind
  • Jul 15, 2026Stuart A TrossChief People & Workpl Officer
    Kind
  • Jul 15, 2026Michael CastagnaChief Executive Officer
    Kind
  • Jul 15, 2026Michael CastagnaChief Executive Officer
    Kind
  • Jul 15, 2026Michael CastagnaChief Executive Officer
    Kind
  • Jul 15, 2026Michael CastagnaChief Executive Officer
    Kind
  • Jul 15, 2026Michael CastagnaChief Executive Officer
    Kind
  • Jul 15, 2026Sanjay R SinghEVP Technical Operations
    Kind
  • Jul 15, 2026Sanjay R SinghEVP Technical Operations
    Kind
  • Jul 15, 2026Sanjay R SinghEVP Technical Operations
    Kind
  • Jul 15, 2026Sanjay R SinghEVP Technical Operations
    Kind
  • Jul 15, 2026Sanjay R SinghEVP Technical Operations
    Kind
  • Jul 15, 2026David ThomsonEVP Genl Counsel & Secretary
    Kind10b5-1
  • Jul 15, 2026David ThomsonEVP Genl Counsel & Secretary
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 17, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by MNKD's officers and directors from 2005 up to November 18, 2025, 21 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%Nov 10, 2026 Latest filing
  • Rubric Capital Management LPwith 1 more person
    Share of class5.83%
  • Vanguard Capital Management
    Share of class5.00%
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • State Street4.70%Nov 10, 202613G
  • The Vanguard Group0.00%Mar 27, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter-56%
  • Millennium Mgmt (Englander)
    In the quarter+113%
  • Renaissance Technologies
    In the quarter
  • AQR Capital
    In the quarter-62%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 8.27% of its shares outstanding were held short, -2.6% since the report before.

Shares held short
25.48M
8.27%
Since the report before26.16M on Sep 30, 2026
-2.6%
5.1
5.04M
More days to cover thanof 4,578 US-listed companies with enough volume
62%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 39.69M
  • Nov 15, 2023: Shares held short 38.82M
  • Nov 30, 2023: Shares held short 38.40M
  • Dec 15, 2023: Shares held short 36.70M
  • Dec 29, 2023: Shares held short 35.57M
  • Jan 12, 2024: Shares held short 35.22M
  • Jan 31, 2024: Shares held short 34.99M
  • Feb 15, 2024: Shares held short 34.65M
  • Feb 29, 2024: Shares held short 35.75M
  • Mar 15, 2024: Shares held short 33.05M
  • Mar 28, 2024: Shares held short 30.76M
  • Apr 15, 2024: Shares held short 31.05M
  • Apr 30, 2024: Shares held short 30.87M
  • May 15, 2024: Shares held short 34.29M
  • May 31, 2024: Shares held short 35.37M
  • Jun 14, 2024: Shares held short 35.77M
  • Jun 28, 2024: Shares held short 34.28M
  • Jul 15, 2024: Shares held short 35.73M
  • Jul 31, 2024: Shares held short 38.57M
  • Aug 15, 2024: Shares held short 38.83M
  • Aug 30, 2024: Shares held short 41.19M
  • Sep 13, 2024: Shares held short 42.14M
  • Sep 30, 2024: Shares held short 42.48M
  • Oct 15, 2024: Shares held short 42.94M
  • Oct 31, 2024: Shares held short 42.87M
  • Nov 15, 2024: Shares held short 42.04M
  • Nov 29, 2024: Shares held short 41.71M
  • Dec 13, 2024: Shares held short 41.36M
  • Dec 31, 2024: Shares held short 28.80M
  • Jan 15, 2025: Shares held short 27.61M
  • Jan 31, 2025: Shares held short 27.29M
  • Feb 14, 2025: Shares held short 27.74M
  • Feb 28, 2025: Shares held short 29.12M
  • Mar 14, 2025: Shares held short 28.59M
  • Mar 31, 2025: Shares held short 28.67M
  • Apr 15, 2025: Shares held short 26.26M
  • Apr 30, 2025: Shares held short 26.11M
  • May 15, 2025: Shares held short 25.82M
  • May 30, 2025: Shares held short 24.80M
  • Jun 13, 2025: Shares held short 24.23M
  • Jun 30, 2025: Shares held short 25.15M
  • Jul 15, 2025: Shares held short 23.76M
  • Jul 31, 2025: Shares held short 23.75M
  • Aug 15, 2025: Shares held short 20.87M
  • Aug 29, 2025: Shares held short 15.89M
  • Sep 15, 2025: Shares held short 16.72M
  • Sep 30, 2025: Shares held short 18.31M
  • Oct 15, 2025: Shares held short 25.16M
  • Oct 31, 2025: Shares held short 23.01M
  • Nov 14, 2025: Shares held short 21.93M
  • Nov 28, 2025: Shares held short 22.09M
  • Dec 15, 2025: Shares held short 20.40M
  • Dec 31, 2025: Shares held short 25.73M
  • Jan 15, 2026: Shares held short 27.30M
  • Jan 30, 2026: Shares held short 26.24M
  • Feb 13, 2026: Shares held short 26.21M
  • Feb 27, 2026: Shares held short 25.61M
  • Mar 13, 2026: Shares held short 22.70M
  • Mar 31, 2026: Shares held short 29.46M
  • Apr 15, 2026: Shares held short 29.58M
  • Apr 30, 2026: Shares held short 29.73M
  • May 15, 2026: Shares held short 29.39M
  • May 29, 2026: Shares held short 30.33M
  • Jun 15, 2026: Shares held short 31.25M
  • Jun 30, 2026: Shares held short 26.19M
  • Jul 15, 2026: Shares held short 28.19M
  • Jul 31, 2026: Shares held short 27.90M
  • Aug 14, 2026: Shares held short 28.58M
  • Aug 31, 2026: Shares held short 26.55M
  • Sep 15, 2026: Shares held short 29.40M
  • Sep 30, 2026: Shares held short 26.16M
  • Oct 15, 2026: Shares held short 25.48M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading48.9% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 48.9% of the shares in the reported trades were short sales, against 47.0% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
48.9%
The 14 beforeOct 12, 2026 – Oct 29, 2026
47.0%
Change
+1.9 pts
Short sales a dayon average, of 1.33M shares
651.4K
More than atof 3,656 US-listed companies, same days
44%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 46.9%
  • Oct 13, 2026: Short sales 44.3%
  • Oct 14, 2026: Short sales 23.8%
  • Oct 15, 2026: Short sales 42.6%
  • Oct 16, 2026: Short sales 59.9%
  • Oct 19, 2026: Short sales 52%
  • Oct 20, 2026: Short sales 62%
  • Oct 21, 2026: Short sales 59.2%
  • Oct 22, 2026: Short sales 51.3%
  • Oct 23, 2026: Short sales 72.5%
  • Oct 26, 2026: Short sales 57.4%
  • Oct 27, 2026: Short sales 54%
  • Oct 28, 2026: Short sales 55.1%
  • Oct 29, 2026: Short sales 56%
  • Oct 30, 2026: Short sales 47.8%
  • Nov 2, 2026: Short sales 54.5%
  • Nov 3, 2026: Short sales 51.7%
  • Nov 4, 2026: Short sales 46.9%
  • Nov 5, 2026: Short sales 60.8%
  • Nov 6, 2026: Short sales 53.8%
  • Nov 9, 2026: Short sales 38.5%
  • Nov 10, 2026: Short sales 42%
  • Nov 11, 2026: Short sales 44.6%
  • Nov 12, 2026: Short sales 41.6%
  • Nov 13, 2026: Short sales 46.9%
  • Nov 16, 2026: Short sales 53.9%
  • Nov 17, 2026: Short sales 50.1%
  • Nov 18, 2026: Short sales 39.1%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

6.14M Insiders' shares1.99% Of the company
  • Michael CastagnaChief Executive Officer
    Directly2.43M
  • Stuart A TrossChief People & Workpl Officer
    Directly1.06M
  • David ThomsonEVP Genl Counsel & Secretary
    Directly797.6K
  • Steven B. BinderDirector
    Directly713.3K
  • Sanjay R SinghEVP Technical Operations
    Directly479.0K
  • Dominic MarascoPres, Endocrine Business Unit
    Directly343.4K
  • Christopher B PrentissChief Financial Officer
    Directly318.7K

A lower bound: it counts only the 7 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

16 ETFs holding it0.34% The largest weight (XBI)
  • XBIState Street(R) SPDR(R) S&P(R) Biotech ETF
    Weight in the fund0.34%
  • LABUDirexion Daily S&P Biotech Bull 3X Shares
    Weight in the fund0.23%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.10%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.08%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.04%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.04%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.03%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.02%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.02%
  • ITOTiShares Core S&P Total U.S. Stock Market ETF
    Weight in the fund0.00%

16 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

260 Managers, Q2 2026$776M Value of their positions
  • Q3 2025: Managers 234
  • Q4 2025: Managers 259
  • Q1 2026: Managers 251
  • Q2 2026: Managers 260

Institutional investors by quarter

The fund managers holding MNKD, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 260 managers held 182M shares, worth $776M. During the quarter 53 opened a position, 44 closed one, 94 added and 61 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter+12%
  • Rubric Capital Management
    In the quarter+397%
  • State Street
    In the quarter-13%
  • Vanguard Capital Management
    In the quarter+2.2%
  • Geode Capital Management
    In the quarter+5.9%
  • Wellington Management Group
    In the quarter+139%
  • Frazier Life Sciences Management
    In the quarter+12%
  • Deep Track Capital
    In the quarter
  • 180 Wealth Advisors
    In the quarter+16%
  • FMR
    In the quarter+18%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do MannKind's filings show?

Who buys and sells is one part of MannKind's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about MNKD's shareholders

Didn't find what you were looking for?

Ask us
Have MNKD's insiders bought or sold?

From Jul 17, 2026 to Sep 28, 2026 MannKind's insiders bought 0 and sold $725.6K of shares on the market. 100% of the sales were under set 10b5-1 plans.

Which well-known managers hold MNKD?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $5.6M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.